Abcellera Biologics Inc (ABCL)

NASDAQ
7.54
+0.04(+0.53%)
  • Volume:
    867,906
  • Day's Range:
    7.42 - 7.71
  • 52 wk Range:
    5.42 - 28.36

ABCL Overview

Prev. Close
7.5
Day's Range
7.42-7.71
Revenue
489.06M
Open
7.52
52 wk Range
5.42-28.36
EPS
0.65
Volume
867,906
Market Cap
2.15B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,763,281
P/E Ratio
11.47
Beta
-
1-Year Change
-76.97%
Shares Outstanding
284,536,212
Next Earnings Date
Aug 11, 2022
What is your sentiment on Abcellera Biologics?
or
Vote to see community's results!

Abcellera Biologics Inc News

  • AbCellera Tops Q1 EPS by 24c
    • ByInvesting.com-

    AbCellera (ABCL) reported Q1 EPS of $0.54, $0.24 better than the analyst estimate of $0.30. Revenue for the quarter came in at $317 million versus the consensus estimate of $179.95...

Abcellera Biologics Inc Company Profile

Abcellera Biologics Inc Company Profile

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong BuySellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • where is this headed? who knows.. but biotech AI is the future.. probably ABCL will be acquired from some big tech company..
    1
    • Avoid expensive sticks, ABCL is expensive even at $10.
      6
      • Decellera...
        1
        • Green in a full red market ( 20.6 dollar)
          1
          • worst stock 2021
            1
            • is its not a bad stock, it is one of the worst performers of 2021... you check the facts
              0
            • You say, "check the facts" as if I'm the one that's incorrect here. People who use that phrase generally don't know what a fact is, and you're Exhibit A. Anyway, you said, "worst stock 2021." There are plenty of stocks that have fared far worse than this one in 2021, just look at TAL and INNV. Hence, my point stands: this is not the worst stock of 2021. You're wrong, and that's ok to be wrong. In any case, I'm up about 30% on it too, while far from being my best performer this year, I got it at a good price.
              2
            • Gregg Alvarezdont care your bs verbose ego. this stock is good but i said is one of the worst performers od 2021, thats a fact.
              1
          • no bottom, i need an ambulance now
            0
            • Buy!!!
              0
              • nope, this will tank further
                0
              • it is long term stock to hold
                0
            • ridiculous
              0
              • wow there is no love for this stock..
                0
                • also we are in ATH in NQ, a good correction or market crash will send this to 12-15 because of the heavy short sellers, we have to hold and ride the waves imao
                  0
                  • i supose we are all bleeding hard in this one lol, so average down
                    0
                  • *could send this more like 15-17
                    0